Male doctor visiting female cancer patient with care and compassion in hospital room. Oncology support medical consultation healthcare and hope. Doctor reporting medical test results to the patient

chanakon laorob

CytomX Therapeutics (CTMX) announced it will receive a $5 million payment after reaching a preclinical milestone in its cancer drug development partnership with Regeneron (REGN). CytomX shares rose 4.6% in extended trading Wednesday.

The payment provides CytomX (CTMX) with

Source link

Leave a Reply

Discover more from Occasional Digest

Subscribe now to keep reading and get access to the full archive.

Continue reading